...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology
【24h】

Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology

机译:基于网络药理学的HERBA围攻和挥发性油挥发油的多元机制及关键活性成分研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background. Herba Siegesbeckiae (HS, Xixiancao in Chinese) is widely used to treat inflammatory joint diseases such as rheumatoid arthritis (RA) and arthritis, and its molecular mechanisms and active ingredients have not been completely elucidated. Methods. In this study, the small molecule ligand library of HS was built based on Traditional Chinese Medicine Systems Pharmacology (TCMSP). The essential oil from HS was extracted through hydrodistillation and analyzed by Gas Chromatography-Mass Spectrometer (GC-MS). The target of RA was screened based on Comparative Toxicogenomics Database (CTD). The key genes were output by the four algorithms’ maximum neighborhood component (MNC), degree, maximal clique centrality (MCC), and stress in cytoHubba in Cytoscape, while biological functions and pathways were also analyzed. The key active ingredients and mechanism of HS and essential oil against RA were verified by molecular docking technology (Sybyl 2.1.1) in treating RA. The interaction between 6 active ingredients (degree?≥?5) and CSF2, IL1β, TNF, and IL6 was researched based on the software Ligplot. Results. There were 31 small molecule constituents of HS and 16 main chemical components of essential oil (relative content 1%) of HS. There were 47 chemical components in HS. Networks showed that 9 core targets (TNF, IL1β, CSF2, IFNG, CTLA4, IL18, CD26, CXCL8, and IL6) of RA were based on Venn diagrams. In addition, molecular docking simulation indicated that CSF2, IL1β, TNF, and IL6 had good binding activity with the corresponding compounds (degree??10).The 6 compounds (degree?≥?5) of HS and essential oil had good interaction with 5 or more targets. Conclusion. This study validated and predicted the mechanism and key active ingredients of HS and volatile oil in treating RA. Additionally, this study provided a good foundation for further experimental studies.
机译:背景。 Herba Siegesbeckiae(HS,西Xianiancao中文)被广泛用于治疗炎症关节疾病,如类风湿性关节炎(RA)和关节炎,其分子机制和活性成分尚未完全阐明。方法。在该研究中,HS的小分子配体文库是基于中药系统药理学(TCMSP)的构建。通过氢化物提取HS的精油,并通过气相色谱 - 质谱仪(GC-MS)分析。基于对比较毒物学数据库(CTD)筛选RA的靶标。通过四种算法的最大邻域组分(MNC),程度,最大Clique中心(MCC),以及Cytoskape中细胞瘤中的胁迫,以及在Cytoscape中的胁迫,以及生物功能和途径的临界基因。通过分子对接技术(Sybyl 2.1.1)治疗RA的关键活性成分和对抗RA的抵抗Ra的机制。基于软件Ligplot研究了6个活性成分(度≥1m)和CSF2,IL1β,TNF和IL6之间的相互作用。结果。 HS和16种HS和16个主要化学成分的HS和16个主要化学成分。 HS中有47种化学成分。网络显示RA的9个核心靶标(TNF,IL1β,CSF2,IFNG,CTLA4,IL18,CD26,CXCL8和IL6)基于VENN图。此外,分子对接模拟表明CSF2,IL1β,TNF和IL6具有良好的结合活性,其具有相应的化合物(度Δ> 10)。HS和精油的6种化合物(Δ≥≤5)具有良好的相互作用有5个或更多目标。结论。该研究证实并预测了HS和挥发油治疗RA的机制和关键活性成分。此外,该研究为进一步的实验研究提供了良好的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号